| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |